Skip to main content
. 2020 Feb 28;2020(2):CD008959. doi: 10.1002/14651858.CD008959.pub3

Summary of findings 2. Home (point‐of‐use) fortification of foods with multiple micronutrient powders versus an iron‐only supplement in children under two years of age.

Population: children 6 to 23 months of age
 Settings: community settings
 Intervention: home fortification with multiple micronutrient powders (duration 2 months)
 Comparison: iron‐only supplement
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
№ of participants
(studies)
Certainty of the evidence (GRADE) Comments
Risk with iron supplements Risk with multiple micronutrient powders
Anaemia (haemoglobin values lower than 110 g/L) Study population RR 0.89
 (0.58 to 1.39) 145
(1 RCT)
⊕⊕⊝⊝
 Lowa
467 per 1000 415 per 1000
 (271 to 649)
Iron deficiency (as defined by trialists) Not measured
Haemoglobin concentration (g/L) Mean haemoglobin concentration ranged across control groups from 101 g/L to 110 g/L Mean haemoglobin concentration in intervention groups was, on average, 2.81 g/L lower (10.84 lower to 5.22 higher) 278
(2 RCTs)
⊕⊝⊝⊝
 Very lowa,b
Iron status (as defined by trialists) Not measured
Weight‐for‐age (z scores) Not measured
All‐cause mortality Not measured
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence.High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
 Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
 Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
 Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

aDowngraded two levels due to small sample size and wide 95% CI.
 bDowngraded one level due to considerable statistical heterogeneity and inconsistency in the results between trials.